- Home
- ONCO vs VRPX Comparison
ONCO vs VRPX Comparison
Compare ONCO & VRPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- VRPX
- Stock Information
- Founded
- ONCO 2018
- VRPX 2016
- Country
- ONCO United States
- VRPX United States
- Employees
- ONCO N/A
- VRPX N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- VRPX Medicinal Chemicals and Botanical Products
- Sector
- ONCO Health Care
- VRPX Health Care
- Exchange
- ONCO Nasdaq
- VRPX Nasdaq
- Market Cap
- ONCO 5.8M
- VRPX 6.0M
- IPO Year
- ONCO 2022
- VRPX 2021
- Fundamental
- Price
- ONCO $0.40
- VRPX $0.26
- Analyst Decision
- ONCO
- VRPX Hold
- Analyst Count
- ONCO 0
- VRPX 1
- Target Price
- ONCO N/A
- VRPX N/A
- AVG Volume (30 Days)
- ONCO 9.9M
- VRPX 8.8M
- Earning Date
- ONCO 04-10-2025
- VRPX 03-25-2025
- Dividend Yield
- ONCO N/A
- VRPX N/A
- EPS Growth
- ONCO N/A
- VRPX N/A
- EPS
- ONCO N/A
- VRPX N/A
- Revenue
- ONCO $1,870,605.00
- VRPX N/A
- Revenue This Year
- ONCO N/A
- VRPX N/A
- Revenue Next Year
- ONCO N/A
- VRPX N/A
- P/E Ratio
- ONCO N/A
- VRPX N/A
- Revenue Growth
- ONCO N/A
- VRPX N/A
- 52 Week Low
- ONCO $0.32
- VRPX $0.23
- 52 Week High
- ONCO $21.40
- VRPX $5.48
- Technical
- Relative Strength Index (RSI)
- ONCO 33.18
- VRPX 40.47
- Support Level
- ONCO $0.58
- VRPX $0.25
- Resistance Level
- ONCO $0.70
- VRPX $0.47
- Average True Range (ATR)
- ONCO 0.06
- VRPX 0.04
- MACD
- ONCO -0.01
- VRPX 0.00
- Stochastic Oscillator
- ONCO 0.00
- VRPX 4.86
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.